Compare AstraZeneca plc (AZN) vs Banco Bilbao Vizcaya Argentaria SA (BBVA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
AstraZeneca plc vs Banco Bilbao Vizcaya Argentaria SA — how do they compare? AstraZeneca plc trades at $158.56 (market cap $250.84B), while Banco Bilbao Vizcaya Argentaria SA trades at $28.6 (market cap $157.51B). The key difference: AstraZeneca plc is the larger of the two by market cap, and Banco Bilbao Vizcaya Argentaria SA pays the higher dividend (3.8%). Which is the better fit depends on your goals.
| AZN | BBVA | |
|---|---|---|
Market Cap | $250.84B | $157.51B |
Sector | Health | Financials |
52-Week High | $209.48 | $28.50 |
52-Week Low | $147.06 | $17.96 |
Enterprise Value | $278.12B | — |
Dividend Yield | 1.97% | 3.8% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About AstraZeneca plc
A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across several major therapeutic classes, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, and immunology. The majority of sales come from international markets with the United States representing close to one third of its sales.
Read more on AZN →About Banco Bilbao Vizcaya Argentaria SA
Despite its Spanish origins, BBVA generates three quarters of its profits in emerging markets, especially Mexico that contributes nearly half of BBVA's net profit. BBVA is overwhelmingly a retail and commercial bank with corporate and investment banking forming a smaller part of the overall business.
Read more on BBVA →
